Cash flow Evotec SE

Equities

EVT

DE0005664809

Biotechnology & Medical Research

Market Closed - Xetra Other stock markets 16:35:25 18/07/2025 BST			5-day change	1st Jan Change
7.456 ^EUR	+0.59%		+5.82%	-9.02%

07-09	EVOTEC : Deutsche Bank reiterates its Neutral rating	ZD
06-26	EVOTEC : Warburg Research remains its Buy rating	ZD

d6491ba45085.yyy-MkDYszuRNblvVD3xyq4eJYG61wQ3Z-7Fj-RvC04.sn_XeQqvignBco8MJwyrosBpTMqMgn0GU5uJ5KsuMgb_dOdBKYuGbf1Szg

Published financial data: EVOTEC SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	501M	618M	751M	781M	797M
Total Revenues	501M	618M	751M	781M	797M
Cost of Goods Sold, Total	375M	466M	577M	606M	682M
Gross Profit	126M	152M	174M	175M	115M
Selling General & Admin Expenses, Total	76.84M	105M	156M	170M	188M
R&D Expenses	63.94M	72.2M	76.64M	68.53M	50.86M
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses	-66.05M	-65.33M	-79.1M	-64.09M	-45.26M
Other Operating Expenses, Total	74.73M	112M	154M	174M	194M
Operating Income	51.01M	39.23M	20.33M	1M	-78.92M
Interest Expense, Total	-8.46M	-9.25M	-13.15M	-11.74M	-11.7M
Interest And Investment Income	2.91M	2.3M	8.34M	9.26M	2.44M
Net Interest Expenses	-5.56M	-6.96M	-4.81M	-2.48M	-9.26M
Income (Loss) On Equity Invest.	-10.43M	-16.57M	-15.96M	-20.75M	-4.31M
Currency Exchange Gains (Loss)	-6.94M	7.84M	13.08M	-2.5M	4.4M
Other Non Operating Income (Expenses)	252K	-61K	-727K	1.79M	-3.76M
EBT, Excl. Unusual Items	28.34M	23.48M	11.91M	-22.94M	-91.86M
Restructuring Charges	-	-	-	-	-54.93M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-43K	212M	-171M	-9.14M	-38.51M
Gain (Loss) On Sale Of Assets	-50K	-147K	-178K	-	-
Asset Writedown	-3.24M	-683K	-	-5.01M	-
Other Unusual Items	806K	2.6M	5.61M	-43.5M	-8.67M
EBT, Incl. Unusual Items	25.81M	237M	-154M	-80.59M	-194M
Income Tax Expense	19.56M	21.47M	21.7M	3.32M	2.1M
Earnings From Continuing Operations	6.25M	216M	-176M	-83.91M	-196M
Net Income to Company	6.25M	216M	-176M	-83.91M	-196M
Minority Interest	-	-	-	-	-
Net Income - (IS)	6.25M	216M	-176M	-83.91M	-196M
Net Income to Common Incl Extra Items	6.25M	216M	-176M	-83.91M	-196M
Net Income to Common Excl. Extra Items	6.25M	216M	-176M	-83.91M	-196M
Per Share Items
Net EPS - Basic	0.04	1.3	-0.99	-0.47	-1.11
Basic EPS - Continuing Operations	0.04	1.3	-0.99	-0.47	-1.11
Basic Weighted Average Shares Outstanding	154M	166M	177M	177M	177M
Net EPS - Diluted	0.04	1.3	-0.99	-0.47	-1.11
Diluted EPS - Continuing Operations	0.04	1.3	-0.99	-0.47	-1.11
Diluted Weighted Average Shares Outstanding	155M	167M	177M	177M	177M
Normalized Basic EPS	0.12	0.09	0.04	-0.08	-0.32
Normalized Diluted EPS	0.11	0.09	0.04	-0.08	-0.32
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	88.31M	89.32M	81.77M	72.08M	651K
EBITA	63.14M	49.56M	27.75M	7.13M	-72.95M
EBIT	51.01M	39.23M	20.33M	1M	-78.92M
EBITDAR	89.15M	90.22M	82.3M	72.38M	991K
Effective Tax Rate - (Ratio)	75.77	9.06	-14.09	-4.12	-1.08
Total Current Taxes	12.06M	16.4M	13.98M	7.92M	7.43M
Total Deferred Taxes	7.49M	5.07M	7.72M	-4.6M	-5.33M
Normalized Net Income	17.71M	14.68M	7.44M	-14.34M	-57.41M
Interest Capitalized	-	-	-	-	2.62M
Interest on Long-Term Debt	3.12M	3.73M	3.84M	5.83M	4.73M
Non-Cash Pension Expense	80K	98K	110K	-402K	-1.39M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	65.76M	73.52M	77.73M	73.9M	50.45M
Net Rental Expense, Total	840K	895K	526K	298K	340K
Imputed Operating Lease Interest Expense	119K	132K	109K	49.41K	73.12K
Imputed Operating Lease Depreciation	721K	763K	417K	249K	267K
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	5.28M	7.8M	9.92M	9.63M	5.04M
Total Stock-Based Compensation	5.28M	7.8M	9.92M	9.63M	5.04M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	423M	699M	415M	511M	306M
Short Term Investments	59.35M	159M	303M	93.2M	90.41M
Total Cash And Short Term Investments	482M	858M	718M	604M	397M
Accounts Receivable, Total	101M	153M	202M	123M	162M
Other Receivables	21.72M	23.42M	54.42M	80.66M	41.88M
Total Receivables	122M	177M	257M	204M	204M
Inventory	13.58M	25.79M	29.82M	30.89M	31.12M
Prepaid Expenses	9.26M	19.21M	16.95M	18.4M	22.24M
Other Current Assets, Total	31.85M	20.95M	51.67M	45.71M	27.57M
Total Current Assets	659M	1.1B	1.07B	903M	682M
Gross Property Plant And Equipment	476M	686M	921M	1.16B	1.3B
Accumulated Depreciation	-141M	-201M	-271M	-350M	-478M
Net Property Plant And Equipment	336M	485M	650M	807M	824M
Long-term Investments	59M	282M	147M	142M	42.15M
Goodwill	247M	258M	275M	276M	283M
Other Intangibles, Total	99.61M	30.85M	23.82M	15.45M	26.44M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	24.95M	17.36M	10.33M	14.33M	17.33M
Other Long-Term Assets, Total	37.4M	61.98M	77.32M	95.23M	37.82M
Total Assets	1.46B	2.24B	2.26B	2.25B	1.91B
Liabilities
Accounts Payable, Total	42.55M	72.6M	97.28M	134M	85.79M
Accrued Expenses, Total	36M	35.46M	49.22M	50.9M	46.35M
Short-term Borrowings	212K	-	-	-	-
Current Portion of Long-Term Debt	15.18M	36.14M	1.56M	130M	27.11M
Current Portion of Leases	14.62M	14.47M	14.82M	19.12M	19.56M
Current Income Taxes Payable	3.36M	10.6M	8.99M	5.56M	8.52M
Unearned Revenue Current, Total	70.65M	127M	137M	108M	110M
Other Current Liabilities	25.89M	28.47M	29.17M	16.85M	47.44M
Total Current Liabilities	208M	325M	338M	465M	345M
Long-Term Debt	331M	326M	328M	308M	260M
Long-Term Leases	131M	136M	162M	169M	132M
Unearned Revenue Non Current	26.13M	34.48M	206M	155M	187M
Pension & Other Post Retirement Benefits	15.33M	12.95M	12.53M	11.99M	10.22M
Deferred Tax Liability Non Current	20.4M	17.69M	18.52M	18.14M	14.52M
Other Non Current Liabilities	7.78M	5.54M	4.87M	5.46M	10.67M
Total Liabilities	740M	857M	1.07B	1.13B	960M
Common Stock, Total	164M	177M	177M	177M	178M
Additional Paid In Capital	1.03B	1.43B	1.44B	1.45B	1.45B
Retained Earnings	-434M	-216M	-392M	-476M	-672M
Comprehensive Income and Other	-37.52M	-12.64M	-37.4M	-30.64M	-7.35M
Total Common Equity	723M	1.38B	1.19B	1.12B	953M
Minority Interest	-	-	-	-	-
Total Equity	723M	1.38B	1.19B	1.12B	953M
Total Liabilities And Equity	1.46B	2.24B	2.26B	2.25B	1.91B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	164M	176M	177M	177M	177M
ECS Total Common Shares Outstanding	164M	176M	177M	177M	177M
Book Value / Share	4.42	7.81	6.72	6.33	5.37
Tangible Book Value	376M	1.09B	889M	829M	643M
Tangible Book Value Per Share	2.3	6.18	5.03	4.68	3.63
Total Debt	492M	513M	507M	626M	439M
Net Debt	10.04M	-345M	-212M	22.09M	42.62M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	14.87M	12.24M
Debt Equivalent Oper. Leases	6.72M	7.16M	4.21M	2.38M	2.72M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	39.71M	13.07M	16.04M	3.07M	2.14M
Account Code - Inventory Valuation	6	8	8	8	6
Inventories - Raw Materials, Total	13.31M	25.04M	27.92M	25.9M	29.46M
Inventories - Work In Process, Total	279K	750K	1.91M	4.99M	1.67M
Buildings, Total	56.6M	201M	240M	274M	323M
Machinery, Total	181M	258M	335M	401M	498M
Full Time Employees	3.57K	4.2K	4.95K	5.06K	4.74K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	782K	2.1M	2.83M	-	-
Order Backlog	446M	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	6.25M	216M	-176M	-83.91M	-196M
Depreciation & Amortization - CF	41.2M	55.6M	72.68M	86.03M	95.13M
Amortization of Goodwill and Intangible Assets - (CF)	12.13M	10.33M	7.42M	6.12M	5.97M
Depreciation & Amortization, Total	53.33M	65.93M	80.1M	92.16M	101M
Amortization of Deferred Charges, Total - (CF)	2.73M	1.68M	1.56M	822K	518K
(Gain) Loss From Sale Of Asset	-1K	142K	178K	-	-
(Gain) Loss on Sale of Investments - (CF)	-1.53M	-224M	172M	9.14M	48.19M
Asset Writedown & Restructuring Costs	3.24M	683K	-	5.01M	12.2M
(Income) Loss On Equity Investments - (CF)	17.27M	28.43M	15.1M	20.75M	4.31M
Stock-Based Compensation (CF)	5.28M	7.8M	9.92M	9.63M	5.04M
Other Operating Activities, Total	-4.99M	27.95M	-19.51M	-7.22M	111M
Change In Accounts Receivable	-4.18M	-48.03M	-38.43M	-	-
Change In Inventories	-3.63M	-11.65M	-4.41M	-	-
Change In Accounts Payable	2.16M	31.34M	24.55M	-	-
Change in Unearned Revenues	-14.62M	63.08M	182M	-	-
Change In Income Taxes	15.49M	18.85M	29.39M	-	-
Change in Other Net Operating Assets	-32.1M	-55.87M	-73.58M	-9.94M	-68.21M
Cash from Operations	44.72M	122M	203M	36.44M	18.22M
Capital Expenditure	-99.07M	-119M	-181M	-213M	-117M
Sale of Property, Plant, and Equipment	-	-	-	530K	2M
Cash Acquisitions	-10.93M	-410K	-20.86M	2.09M	-
Sale (Purchase) of Intangible assets	-	-	-	-2.68M	-14.77M
Investment in Marketable and Equity Securities, Total	-38.85M	-117M	-209M	190M	49.06M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-6.24M	-7.38M	-4.13M	-	-
Other Investing Activities, Total	-	-	-	10.36M	9.99M
Cash from Investing	-155M	-244M	-416M	-13.29M	-71.19M
Long-Term Debt Issued, Total	21.54M	30.79M	-	220M	900K
Total Debt Issued	21.54M	30.79M	-	220M	900K
Long-Term Debt Repaid, Total	-26.69M	-36.68M	-53.11M	-135M	-153M
Total Debt Repaid	-26.69M	-36.68M	-53.11M	-135M	-153M
Issuance of Common Stock	252M	404M	699K	219K	368K
Other Financing Activities, Total	-	-	-	-12.85M	-9.72M
Cash from Financing	246M	398M	-52.41M	71.96M	-161M
Foreign Exchange Rate Adjustments	9.5M	-66K	-19.04M	644K	9.87M
Miscellaneous Cash Flow Adjustments	-	-	-	-1K	-
Net Change in Cash	146M	277M	-284M	95.75M	-205M
Supplemental Items
Cash Interest Paid	3.46M	5.43M	9.8M	12.85M	5.92M
Cash Income Tax Paid (Refund)	9.8M	-6.03M	18.5M	12.9M	-76.08M
Levered Free Cash Flow	-18.32M	4.87M	-150M	-69.8M	-85.91M
Unlevered Free Cash Flow	-13.03M	10.65M	-142M	-62.47M	-78.6M
Change In Net Working Capital	7.18M	-29.66M	65.06M	-50.29M	3.69M
Net Debt Issued / Repaid	-5.16M	-5.89M	-53.11M	84.6M	-152M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	2.41	1.33	0.57	0.03	-2.37
Return on Total Capital	2.96	1.58	0.71	0.04	-3.14
Return On Equity %	1.04	20.5	-13.7	-7.27	-18.92
Return on Common Equity	1.04	20.5	-13.7	-7.27	-18.92
Margin Analysis
Gross Profit Margin %	25.1	24.52	23.16	22.4	14.41
SG&A Margin	15.34	17.06	20.79	21.71	23.61
EBITDA Margin %	17.63	14.45	10.88	9.22	0.08
EBITA Margin %	12.6	8.02	3.69	0.91	-9.15
EBIT Margin %	10.18	6.35	2.71	0.13	-9.9
Income From Continuing Operations Margin %	1.25	34.87	-23.38	-10.74	-24.6
Net Income Margin %	1.25	34.87	-23.38	-10.74	-24.6
Net Avail. For Common Margin %	1.25	34.87	-23.38	-10.74	-24.6
Normalized Net Income Margin	3.54	2.37	0.99	-1.83	-7.2
Levered Free Cash Flow Margin	-3.66	0.79	-20.01	-8.93	-10.78
Unlevered Free Cash Flow Margin	-2.6	1.72	-18.91	-7.99	-9.86
Asset Turnover
Asset Turnover	0.38	0.33	0.33	0.35	0.38
Fixed Assets Turnover	1.75	1.5	1.32	1.07	0.98
Receivables Turnover (Average Receivables)	5.12	4.87	4.23	4.8	5.58
Inventory Turnover (Average Inventory)	30.84	23.69	20.76	19.97	22
Short Term Liquidity
Current Ratio	3.16	3.39	3.18	1.94	1.98
Quick Ratio	2.9	3.19	2.89	1.74	1.74
Operating Cash Flow to Current Liabilities	0.21	0.38	0.6	0.08	0.05
Days Sales Outstanding (Average Receivables)	71.45	74.96	86.37	76.07	65.61
Days Outstanding Inventory (Average Inventory)	11.87	15.41	17.58	18.27	16.64
Average Days Payable Outstanding	35.76	43.9	53.32	69.58	59.03
Cash Conversion Cycle (Average Days)	47.56	46.46	50.63	24.76	23.22
Long Term Solvency
Total Debt/Equity	68.06	37.23	42.68	55.92	46.13
Total Debt / Total Capital	40.5	27.13	29.91	35.86	31.57
LT Debt/Equity	63.91	33.56	41.3	42.6	41.23
Long-Term Debt / Total Capital	38.03	24.45	28.95	27.32	28.22
Total Liabilities / Total Assets	50.59	38.36	47.41	50.28	50.19
EBIT / Interest Expense	6.03	4.24	1.55	0.09	-6.75
EBITDA / Interest Expense	12.33	11.36	7.64	7.94	1.9
(EBITDA - Capex) / Interest Expense	0.62	-1.49	-6.15	-10.24	-8.14
Total Debt / EBITDA	4.71	4.88	5.05	6.72	19.81
Net Debt / EBITDA	0.1	-3.28	-2.11	0.24	1.92
Total Debt / (EBITDA - Capex)	93.35	-37.2	-6.26	-5.21	-4.61
Net Debt / (EBITDA - Capex)	1.9	25.04	2.62	-0.18	-0.45
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.2	23.38	21.59	3.99	1.99
Gross Profit, 1 Yr. Growth %	-5.38	20.52	14.86	0.57	-34.37
EBITDA, 1 Yr. Growth %	-17.97	0.53	-8.46	-14.01	-99.1
EBITA, 1 Yr. Growth %	-27.21	-21.05	-44	-75.71	-1.12K
EBIT, 1 Yr. Growth %	-32.22	-22.55	-48.18	-95.19	-7.97K
Earnings From Cont. Operations, 1 Yr. Growth %	-83.21	3.33K	-181.51	-52.23	133.67
Net Income, 1 Yr. Growth %	-83.58	3.33K	-181.51	-52.23	133.67
Normalized Net Income, 1 Yr. Growth %	-59.85	-11.3	-49.29	-272.55	300.45
Diluted EPS Before Extra, 1 Yr. Growth %	-84	3.14K	-176.77	-52.29	134.03
Accounts Receivable, 1 Yr. Growth %	5.72	52.57	31.94	-39.01	31.57
Inventory, 1 Yr. Growth %	26.38	89.86	15.63	3.57	0.75
Net Property, Plant and Equip., 1 Yr. Growth %	41.06	43.67	34.17	24.05	2.15
Total Assets, 1 Yr. Growth %	23.88	52.85	0.99	-0.21	-15.09
Tangible Book Value, 1 Yr. Growth %	265.32	187.37	-18.43	-6.72	-22.39
Common Equity, 1 Yr. Growth %	51.53	90.17	-13.83	-5.67	-14.95
Cash From Operations, 1 Yr. Growth %	5.93	173.33	66.16	-82.3	-50
Capital Expenditures, 1 Yr. Growth %	216.3	20.06	52.47	17.63	-44.93
Levered Free Cash Flow, 1 Yr. Growth %	-156.17	-126.24	-3.19K	-52.99	23.08
Unlevered Free Cash Flow, 1 Yr. Growth %	-134.95	-180.35	-1.43K	-55.46	25.83
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	15.51	17.66	22.48	12.44	2.98
Gross Profit, 2 Yr. CAGR %	5.95	6.79	17.66	7.48	-18.76
EBITDA, 2 Yr. CAGR %	-3.1	-9.41	-5.66	-10.17	-92.09
EBITA, 2 Yr. CAGR %	-8.56	-24.58	-35.05	-62.08	87.05
EBIT, 2 Yr. CAGR %	-10.89	-27.57	-37.39	-84.01	94.55
Earnings From Cont. Operations, 2 Yr. CAGR %	-72.73	140.33	428.96	-37.6	5.65
Net Income, 2 Yr. CAGR %	-72.75	137.66	428.96	-37.6	5.65
Normalized Net Income, 2 Yr. CAGR %	-30.74	-42.09	-34.41	-1.16	162.87
Diluted EPS Before Extra, 2 Yr. CAGR %	-73.27	127.6	398.56	-39.48	5.66
Accounts Receivable, 2 Yr. CAGR %	28.42	27	41.88	-10.29	-10.42
Inventory, 2 Yr. CAGR %	54.92	54.91	48.17	9.44	2.15
Net Property, Plant and Equip., 2 Yr. CAGR %	93.88	42.69	38.84	29.01	12.57
Total Assets, 2 Yr. CAGR %	37.67	37.58	24.24	0.39	-7.95
Tangible Book Value, 2 Yr. CAGR %	118.1	225.38	53.11	-12.77	-14.92
Common Equity, 2 Yr. CAGR %	30.57	69.94	28.01	-9.84	-10.43
Cash From Operations, 2 Yr. CAGR %	-46.5	70.16	113.11	-45.4	-70.25
Capital Expenditures, 2 Yr. CAGR %	88.55	94.87	35.3	33.92	-19.52
Levered Free Cash Flow, 2 Yr. CAGR %	-56.45	-61.18	190.69	278.73	-21.74
Unlevered Free Cash Flow, 2 Yr. CAGR %	-63.58	-46.32	237.18	142.19	-25.14
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	23.84	18.08	18.95	15.98	8.85
Gross Profit, 3 Yr. CAGR %	15.41	10.6	9.41	11.66	-8.82
EBITDA, 3 Yr. CAGR %	16.32	-1.7	-9.09	-7.77	-80.61
EBITA, 3 Yr. CAGR %	13.92	-13.09	-31.7	-52.33	13.76
EBIT, 3 Yr. CAGR %	11.72	-15.16	-35.22	-73.16	26.24
Earnings From Cont. Operations, 3 Yr. CAGR %	-35.42	36.87	67.6	137.32	-3.1
Net Income, 3 Yr. CAGR %	-35.66	36.8	66.35	137.32	-3.1
Normalized Net Income, 3 Yr. CAGR %	2.36	-26.48	-44.6	-6.07	57.57
Diluted EPS Before Extra, 3 Yr. CAGR %	-37	32.24	58.43	128.03	-5.01
Accounts Receivable, 3 Yr. CAGR %	21.01	36.01	28.63	7.08	1.92
Inventory, 3 Yr. CAGR %	34.62	65.79	40.52	31.5	6.46
Net Property, Plant and Equip., 3 Yr. CAGR %	64.93	75.72	39.79	33.72	19.35
Total Assets, 3 Yr. CAGR %	29.96	42.53	24.1	15.49	-5.06
Tangible Book Value, 3 Yr. CAGR %	144.25	139.78	105.17	29.79	-16.1
Common Equity, 3 Yr. CAGR %	29.75	48.11	35.52	15.63	-11.57
Cash From Operations, 3 Yr. CAGR %	60.44	-7.86	68.82	-6.6	-46.98
Capital Expenditures, 3 Yr. CAGR %	79.16	62.21	79.57	29.13	-0.42
Levered Free Cash Flow, 3 Yr. CAGR %	41.98	-63.07	66.97	57.72	160.38
Unlevered Free Cash Flow, 3 Yr. CAGR %	21.92	-52.31	56.67	70.96	94.7
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	31.44	30.31	23.29	15.79	12.29
Gross Profit, 5 Yr. CAGR %	29.05	20.95	16.3	9.34	-2.87
EBITDA, 5 Yr. CAGR %	64.27	20.48	7.82	-5.18	-64.08
EBITA, 5 Yr. CAGR %	109.01	14.35	-8.26	-37.63	-3.49
EBIT, 5 Yr. CAGR %	73.58	10.02	-11.09	-56.48	1.09
Earnings From Cont. Operations, 5 Yr. CAGR %	-17.66	51.68	49.89	-0.03	39.35
Net Income, 5 Yr. CAGR %	-17.66	50.91	49.56	-0.06	38.73
Normalized Net Income, 5 Yr. CAGR %	64.24	-3.03	-14.74	-17.24	5.58
Diluted EPS Before Extra, 5 Yr. CAGR %	-19.73	45.3	44.1	-3.27	34.73
Accounts Receivable, 5 Yr. CAGR %	36.68	40.21	28.96	15.15	11.3
Inventory, 5 Yr. CAGR %	34.1	43.06	39.89	40.41	23.69
Net Property, Plant and Equip., 5 Yr. CAGR %	54.48	62.46	54.1	55.29	28.19
Total Assets, 5 Yr. CAGR %	38.36	44.56	27.63	23.89	10.12
Tangible Book Value, 5 Yr. CAGR %	26.83	63.27	102.97	60.01	44.28
Common Equity, 5 Yr. CAGR %	31.26	45.26	29.11	21.44	14.83
Cash From Operations, 5 Yr. CAGR %	23.37	12.66	79.74	-25.26	-15.47
Capital Expenditures, 5 Yr. CAGR %	54.81	64.6	60.12	50.24	30.26
Levered Free Cash Flow, 5 Yr. CAGR %	-8.24	-24.77	88.01	-6.29	21.61
Unlevered Free Cash Flow, 5 Yr. CAGR %	-14.93	-12.81	81.64	-8.65	16.29